NewLife BioChemEX
NL BiochemEx is dedicated to developing easy-to-use diagnostic tests with a focus on rapid and accurate diagnosis for early treatment, epidemic prevention, and health surveillance. They support health care through innovative research, in vitro diagnostic tests, and spatial omics technology, aiming to redefine health diagnostics and contribute to epidemic and pandemic disease detection.
Industries
Nr. of Employees
small (1-50)
NewLife BioChemEX
Gaithersburg, Maryland, United States, North America
Products
Paper-based NAAT point-of-care diagnostic (in development)
A point-of-care nucleic acid amplification test built on paper for room-temperature storage, rapid results and simplified readout for use by minimally trained operators.
Multiplex IFNα profiling assay (in development)
Multiplex diagnostic assay targeting trace levels of type I interferon (IFNα) for early-phase infection profiling and risk stratification of disease progression.
Spatial omics assay and reagent suite (service/product)
Platform and reagent set for in-situ sequencing and multiplex spatial detection of DNA, RNA and protein targets for research and diagnostic applications.
Paper-based NAAT point-of-care diagnostic (in development)
A point-of-care nucleic acid amplification test built on paper for room-temperature storage, rapid results and simplified readout for use by minimally trained operators.
Multiplex IFNα profiling assay (in development)
Multiplex diagnostic assay targeting trace levels of type I interferon (IFNα) for early-phase infection profiling and risk stratification of disease progression.
Spatial omics assay and reagent suite (service/product)
Platform and reagent set for in-situ sequencing and multiplex spatial detection of DNA, RNA and protein targets for research and diagnostic applications.
Services
Fee-for-service preclinical studies including early-stage screening, pharmacology, efficacy assessment and in-vitro/in-vivo model support.
Custom sandwich and direct ELISA development and validation for measurement of total and specific immunoglobulins.
Process and analytical development services for viral vectors, supporting supply for clinical and commercial applications.
Customization and execution of flow cytometry assays with project setup and reporting to support clinical research and drug development.
Statistical analysis, data processing, visualization and report generation for experimental and contract study data.
In-vitro antibody discovery and production services optimized for increased yield in serum and serum-free systems.
Fee-for-service preclinical studies including early-stage screening, pharmacology, efficacy assessment and in-vitro/in-vivo model support.
Custom sandwich and direct ELISA development and validation for measurement of total and specific immunoglobulins.
Process and analytical development services for viral vectors, supporting supply for clinical and commercial applications.
Customization and execution of flow cytometry assays with project setup and reporting to support clinical research and drug development.
Statistical analysis, data processing, visualization and report generation for experimental and contract study data.
In-vitro antibody discovery and production services optimized for increased yield in serum and serum-free systems.
Expertise Areas
- Spatial omics and in‑situ sequencing
- Point-of-care molecular diagnostics (paper-based NAAT)
- Preclinical contract research (in-vitro and in-vivo)
- Immunoassay development and validation
Key Technologies
- Spatial omics
- In-situ gene sequencing
- FISH-based DNA/RNA/protein detection
- Single-cell single-molecule RNA detection